Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I contacted IR on Friday and asked if they still hold the same timeline for the submission of the application. He said they remain committed to submitting the modified risk application to the FDA by the end of the year. Looks to still be on track.
Next court date moved to 11/16, FYI
The qty of granted patents increased from 128 to 185. I thought that was pretty interesting. Keep building the IP along with the rest of the business.
My personal opinion would be to let it go. Move on. Any press release could sound petty and keep the non-issue going.
He did answer it, and quite well I thought. The interviewer was stuck on the question though and was almost defending the attributes of nicotine, saying he's heard nicotine improves concentration.
In the end, it was way to short. It would be ideal to see a write-up on it in a journal or paper rather than a 1 minute interview.
The 22nd Century v Brink case was settled via mediation. Good outcome for XXII. Less time in court fighting over a bad business transaction.
"A mediation conference was held on March 26, 2015 with additional discussions
thereafter. The case has been completely settled. The parties separately
will file a notice of settlement which will request 150 days (in lieu
of the normal 60) within which to file their joint dismissal pursuant
to Local Rule 3.08(b)."
Regarding this case, there is a counter-claim now from the defendants.
Mostly a boring read, but what is confirmed in this court document is that Joe was telling this Brink guy last July that a deal with Chinese National Tobacco Corporation was imminent and that it would result in an immediate cash infusion that would help fund the acquisition. Obviously, China has yet to materialize, but I don't believe it was ever confirmed (only assumed) that CNTC was the party on the other side of the table. This counter-claim confirms it.
Besides that, this is a contract law case that will have no bearing on XXII, win or lose.
Oddly enough, he was named a Director on the Board after a license agreement in November between Naturally Splendid and Spectrum Laboratories and Boreal Technologies. If I'm reading this correctly, this was the same kind of license agreement that was in the works with XXII.
So XXII backed out and Naturally Splendid slid in.
http://thenewswire.ca/archives?tnwcatalyst2=release_id%3D15696
I put the PDF up on this link. Hopefully it works. Very interesting.
http://www.view-pdf.com/ViewPDFFile.aspx?file=http://www.htmlpublish.com/newTestDocStorage/DocStorage/8f47c0ead2f144eba74eb69659db3870/22nd%20Century%20v%20Brink.pdf
I can't provide a direct link to the complaint as it's password protected through the site in which I got access, but try this....
http://www.law360.com/cases/54359ecc1fc806689d000003 and then click on View recent docket activity. Do a free 7-day trial and hopefully you get access to the docket and the complaint.
Has the 22nd Century v Brink case gotten any discussion on here? I just noticed it and have been reading the complaint....very interesting read. Civil suit where XXII is seeking damages from Charles Brink and Spectrum Universal, who looks to be some kind of cannabis/hemp company. Interesting read into what XXII was trying to do with the Cannabis angle last summer. It sounds like there was a letter of intent, but XXII backed out after discovering Brink falsified info to sell the company. Jury trial set for next January.
I did the other day. I expressed that there is shareholder interest in getting a permanent CEO in place soon, whether it be Henry or someone else. It sounded like the BOD has met with a number of suitors in its search process. If I were to guess, I'd say we don't go too much longer on this topic. I think it will be Henry in the end and if it is, he has the goods to get it done. I'm not a fan of the delay in the hire either, which is why I asked.
Me too. 18k more shares. XXII you now have my permission to head the other way.
It's on November 12th per the 9/25 PR
"Waiting for georgejji to add his prolific opinions"
Just sign off and sign back in with your other username and then start typing your alter ego Georgie's opinions.
We need a streaker during the bell ringing to help expose the XXII goods. Who wants to take a hit for the team?
Mr Smith is obviously concerned about what Sphere 3D has to offer. If their technology is successful, they pose a major threat to his business. If he truly thought they were a fly on the wall and that their tech didn't have potential to disrupt, then why would he spend so much time trying to discredit it?
PS. If my VP of Business Development had tweeted 13,000 times in 3 years, I'd be very worried about his productivity. Most teenage girls don't even have those Twitter stats.
A follow-up to my earlier post...
I emailed the WSJ reporter who wrote the 2012 article as I noticed his area of reporting is the beverage and tobacco industry.
It was a brief message to simply see if he knew much of 22nd Century and I also provided a background of the company (specifically highlighting China possibilities as that was the topic of his 2012 article).
He replied to me tonight stating, "Thanks xxxx, I’ve been in touch with 22nd Century and saw Herzog’s write-up."
Short and simple reply, but I was happy to see he had already been in touch with the company, presumably due to Bonnie's call.
You sure are minding that gap. I personally prefer the Chive's methodology regarding gaps.
http://thechive.com/2013/11/04/mind-the-gap-35-photos-2/
This article is from 2012, but I found a few sections of it pretty interesting in regards to XXII's potential China partnership. Phillip Morris is going to great lengths and spending a lot of money to get greater market share in China. I can't imagine they'd be pleased if XXII pulled off a partnership. They aren't happy with their .3% market share in China...which by the way was still 2 billion cigarettes sold.
http://online.wsj.com/news/articles/SB10000872396390444657804578052664166255722
At a recent investor conference, Philip Morris acknowledged traditional cigarettes from foreign companies will continue to be a hard sell in China, where the government generates tens of billions of dollars in profits from tobacco. Retail cigarette sales in the country topped $160 billion in 2011, roughly a quarter of the global market, according to estimates by Euromonitor, a data service.
"Why would they share their market?'' Philip Morris Chairman and Chief Executive Louis Camilleri told investors in June. "To come up with new technology is really the only avenue to get into a place like China.''
Philip Morris is investing hundreds of millions of dollars trying to develop less-harmful cigarettes and executives have described the strategy as a potential "game changer''in China. One version generates smoke at temperatures below combustion, releasing fewer toxins, but aims to mimic traditional cigarettes more closely than alternatives already on the market such as electronic cigarettes.
It would have been nice if they identified their affiliation, but my guess is the 1st few callers might have been analysts. Just judging based on their questions and knowledge in comparison to the final few callers.
All I know is that Bonnie and others sure were interested in China.
Did the boys at the dirt sheet tag team your wife or something?
You're giving Jim Hoft a run for his money.
I know, I know. Post removed in 3,2,1...
It sounds like you missed my point of bringing up that other company. I was not comparing the two. They are completely different and it looks like that company rode the e-cig wave.
I was simply pointing out that the CEO was a guest on the Tobacco Talk call (the first one in the series) and the company took off after that. Was it related? I don't know. What happened to cause the drop 16 months later is of no interest. I was just interested to see if the Tobacco Talk call had much of a track record in helping exposure.
Oh snap, you went all caps. You've got my attention now.
The Tobacco Talk itself isn't a catalyst, but it certainly doesn't hurt. I can only identify 3 other Tobacco Talk calls in which a company CEO was the feature guest. Two were privately held, but the third is a public company and quadrupled a month after the call (VPCO).
There could have been other developments at play to help the quadruple, but regardless I'm sure the attention from the call didn't hurt.
Good catch. Interesting, indeed.
28, yet bragging on a message board on a Saturday night about your corporate climbing success. With all your assets, you should be out on a Saturday night wooing the ladies. Be sure to use the line that you've lived in 6 cities. It's a deal closer.
No thanks, boss. That wasn't my point. Just calling you out for your super positive post about not selling while behind the scenes you were doing just that.
The point is...you are not to be believed.
You're transparency is humorous. On the 11th at 10:34, you said, "No way I'm selling," and you gave your reasons.
The only time it touched your sell point of 5.98 was in the half hour following. It hasn't touched 5.98 since.
Kudos to your sale if it's true...it looks good now. I'm just laughing because I picture you hitting the sell button as you type "No way I'm selling."
Warren B's quote comes to mind when I read your posts.
"The stock market remains an exceptionally efficient mechanism for the transfer of wealth from the impatient to the patient."
The timing of your XXII purchase wasn't ideal, but you're still in a great position to make good money here if your patient.
Good luck with your decision.
You forgot one.
Regarding orphan drug review, it looks like 90 days is the target by the FDA. Based on this link, almost all orphan drug reviews are completed in 90 days or less.
http://www.accessdata.fda.gov/FDATrack/track?program=osmp&id=OSMP-OOPD-Percentage-orphan-drug-designation-reviewed-completed-in-90-days-or-less
Good to see they'll be presenting at Rodman and Crenshaw again in September (8th-10th). The days of the conference last year had all-time highs for volume (at the time) and a nice jump in SP in the weeks after.